Latest News and Press Releases

Pharmala announces a newly signed contract to supply a clinical trial, and the fulfillment of a previously announced trial.

PharmAla to receive clinical trial data from harvard-affiliated hospital in exchange for a drug donation

PharmAla to supply University of Amsterdam with LaNeo MDMA for a clinical trial, generating new stability data for blister packs in the process

PharmAla ships MDMA to Mt. Sinai Hospital and starts making patented novel MDMA-like drug, preparing for a phase 2 clinical trial into Social Anxiety.

PharmAla completes delivery of a Phase 3 clinical trial contract after finishing release testing on an australian-made batch of LaNeo MDMA.

PharmAla launches new web portal for MDMA prescribers and appoints a new COO

PharmAla releases Q2 financial statements showing increased customer deposits, shipments

PharmAla sidesteps tariff risk and expands clinical operations in the United States by contracting with Sharp Clinical Services as distribution partner

PharmAla completes shipment of MDMA to University of Washington, to be used in a Narcissism clinical trial. It also appoints Ali Taghva as CCO.

PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial